BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang DQ, Nguyen MH. Letter: hepatocellular carcinoma risk in patients with non-selective beta blockers. Aliment Pharmacol Ther 2021;54:1093-4. [PMID: 34564887 DOI: 10.1111/apt.16576] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Cheng HY, Lin HC, Lin HL, Uang YS, Keller JJ, Wang LH. Association Between Nonselective Beta-Blocker Use and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Without Cirrhosis and Decompensation. Front Pharmacol 2021;12:805318. [PMID: 35069216 DOI: 10.3389/fphar.2021.805318] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wijarnpreecha K, Li F, Dang Y, Taner CB, Yang L, Tao C. Letter: hepatocellular carcinoma risk in patients with non-selective beta blockers-authors' reply. Aliment Pharmacol Ther 2021;54:1095-6. [PMID: 34564885 DOI: 10.1111/apt.16598] [Reference Citation Analysis]